Global Health's revenue increased 25.3% YoY
  • 15 May 2026
  • Global Health Ltd reported a 4.6% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Mar (Q4 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 25.3%.
  • Its expenses for the quarter were up by 2.2% QoQ and 30.8% YoY.
  • The net profit increased 49.1% QoQ and increased 39.7% YoY.
  • The earnings per share (EPS) of Global Health Ltd stood at 5.35 during Q4 FY 2025-26.

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Global Health Ltd is a company involved in the healthcare industry. Typically, companies in this sector are engaged in providing health-related services, which may range from hospital management to healthcare technology solutions. However, specific details about Global Health Ltd's exact product lines or services are not available in the provided data. Additionally, no recent major developments or changes in the company's business operations are mentioned. Therefore, the analysis will focus on the financial data provided without additional context about potential industry or company-specific influences.

In the fourth quarter of fiscal year 2026 (Q4FY26), Global Health Ltd reported a total income of ₹1,195.79 crores. This represents a 4.6% increase from the previous quarter (Q3FY26), where total income was ₹1,142.83 crores. Compared to the same quarter in the previous year (Q4FY25), where the total income was ₹954.18 crores, the company experienced a year-over-year growth of 25.3%. This upward trend in revenue indicates a strong performance in total income across both quarterly and annual comparisons.

The profitability of Global Health Ltd in Q4FY26 is demonstrated by a profit before tax of ₹187.28 crores. This marks a significant quarter-over-quarter increase of 56.4% from Q3FY26, where the profit before tax was ₹119.78 crores. Year-over-year, there was a 40.3% increase compared to the profit before tax of ₹133.44 crores in Q4FY25. After accounting for taxes, the profit after tax for Q4FY26 stood at ₹141.65 crores, reflecting a 49.1% increase from Q3FY26 and a 39.7% increase from Q4FY25. The earnings per share (EPS) also rose, reaching ₹5.35 in Q4FY26, up from ₹3.54 in Q3FY26 and ₹3.77 in Q4FY25, representing QoQ and YoY increases of 51.1% and 41.9%, respectively.

Global Health Ltd's total expenses for Q4FY26 were ₹1,008.51 crores, which was a 2.2% increase from the previous quarter's expenses of ₹986.45 crores. Year-over-year, total expenses increased by 30.8% compared to ₹770.84 crores in Q4FY25. The tax expense for Q4FY26 was ₹45.63 crores, demonstrating an 84.4% rise from Q3FY26 and a 42.3% increase from Q4FY25. These figures highlight the company's operating costs and tax obligations, contributing to the overall financial performance and impacting the net profitability calculations.

Global Health Ltd announced its Q4 FY 2025-26 results on 15 May, 2026.

Global Health Ltd quarterly results refer to the company’s financial performance over a three-month period, including key metrics like revenue, net profit, earnings per share (EPS), and margin performance.

Key highlights of Global Health Ltd Q4 FY 2025-26 results include:

  • Revenue: ₹1195.79 crore
  • Net Profit: ₹141.65 crore
  • EBITDA: ₹280.50 crore
  • Year-over-Year Growth: 25.3%
  • Quarter-over-Quarter Growth: 4.6%

Global Health Ltd reported a net profit of ₹141.65 crore in Q4 FY 2025-26, reflecting a 39.7% year-over-year growth.

Global Health Ltd posted a revenue of ₹1195.79 crore in Q4 FY 2025-26.